Tourmaline Bio
Cathy Andorfer, Ph.D., serves as the National Director Field Medical at Tourmaline Bio since May 2024, leading a team of Regional Medical Directors and overseeing field activities. Prior to this role, Cathy was with Bristol Myers Squibb from August 2020 to May 2024 as Lead US Dermatology Field Medical, where significant accomplishments included building a national dermatology field medical team, expanding into rheumatology, and successfully launching SOTYKTU. Experience also includes roles at Dermira, Inc., where Cathy was Senior Director of the Field Medical Team responsible for launching Qbrexza and fostering important relationships in dermatology, and previous positions at Biogen and Mayo Clinic focusing on Alzheimer’s disease and translational research. Educational qualifications include a Ph.D. in Neuroscience from Albert Einstein College of Medicine and a Master's degree in Biology/Animal Physiology from the University of Notre Dame.
This person is not in any teams
This person is not in any offices
Tourmaline Bio
2 followers
Tourmaline is a late-stage clinical biotechnology company driven by our mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune and inflammatory diseases. In doing so, we seek to develop assets medicines that have the potential to establish new standards-of-care in areas of high unmet medical need.